Quote:Leronlimab front page news after saving a young Dad!
That was not leronlimab but Agenus' Botensilimab/Balstilimab. They had been hoping for a path to accelerated approval but denied by FDA. They are conducting a phase 3 trial. Their CEO has written op-eds bashing FDA.
Dr. DeVito saw results that were presented at a conference and jumped through hoops to get funding to initiate a trial in the first line setting without chemo.
Hoping Dr. DeVito or others like him will see our results and do the same with leronlimab.